Harpoon stock: buy or sell?
December 6th, 2019
Should I buy Harpoon stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. That's why is so important to define your own trading plan that matches with your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Harpoon stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Harpoon stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we collected 4 ratings published for HARP stock in the last month. The general sentiment of these ratings is bullish for HARP stock, with 4 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
Harpoon stock analysis
After marking all time highs today, Harpoon climbed 5.64% today to $18.93.
Harpoon topped new all time highs back again today, setting highs to $21.26. Shares closed at $18.93 and climbed 5.64%. From a daily perspective, HARP is in a short term uptrend after plotting its last bottom ($13.00, on November 18th) higher than the previous bottom, and its last top ($19.99, on Nov 29th) also over the previous top. Now trading in between its last bottom and last top HARP might consolidate in a plain range, waiting to break out over $19.99 or down under $13.00. On Monday, SMA50d and SMA100d crossed up triggering a rise of 1.23%. Since price and SMA100d lines crossed up on Nov 19th, HARP climbed $5.15 (37.37%).
After boosting an exceptional 20.59% in a week last week, Harpoon Therapeutics closed this week at $18.93 and inched a slightly good 1.23%. This week was the 4th green week in a row. Early November HARP plummed a scary -6.24% in just one week.
HARP shows a strong mid-term uptrend with several rising tops and rising bottoms. Since its last bottom by mid October, HARP climbed unceasignly breaking out to new all time highs. It touched new all-time highs back again this week, topping to $21.26. By mid November HARP price bounced up over the SMA of 40 weeks that acted as support stopping new slides.
Harpoon stock price history
Harpoon IPO was on February at $14.00 per share1. Since then, HARP stock grew a 35.20%, with a yearly average of inf%. If you had invested $1,000 in Harpoon stock in 2019, it would worth $352.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Harpoon stock historical price chart
HARP stock reached all-time highs today with a price of $21.26.
Harpoon stock price target is $23.30Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. We detected 4 price targets for Harpoon Therapeutics stock published in the last 30 days:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter presenting its last earnings report on March, Harpoon Therapeutics . Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual turnover report draw an exceptional growth of 570.90% to $4.75 M dollars. Likewise, its profit margin (compared to sales) skyrocketed to -576.13%, that is $-27.37 million.
|2017||$0.71 M||-||$-16.83 M-2377.1%||-|
|2018||$4.75 M||570.90%||$-27.37 M-576.1%||62.60%|
Quarterly financial resultsHarpoon posted $1.06 M in revenues for 2018-Q4, a inf% improvement compared to previous quarter. Reported quarter earnings marked $-9.73 M with a profit margin of -916.29%. Profit margin stayed constant a 0.00% compared to previous quarter when profit margin was nan%. When comparing revenues to same quarter last year, Harpoon Therapeutics sales marked an extraordinary increase and boosted a 50.00%.
|2017-Q4||$0.71 M||-||$-4.94 M-697.7%||-|
|2018-Q4||$1.06 M||50.00%||$-9.73 M-916.3%||96.98%|
Harpoon ownershipWhen you are planning to invest in shares of a company, it's always worth to overview its ownership structure.
Harpoon Therapeutics shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 29.85% of all shares.
In case of Harpoon Therapeutics stock, 41.36% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for HARP stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Harpoon:
|Market cap||$466.4 M|
|Total shares||24.6 M|
|Float shares||9.6 M|
|- Institutional holdings (%)||41.4%|
|- Insider holdings (%)||29.8%|
|Shares in short selling||0.0%|
|Friday, December 6th, 2019|
|Day range||$18.08 - $21.26|
|Average true range||$1.69|
|50d mov avg||$14.38|
|100d mov avg||$14.20|
|200d mov avg||$13.19|
Harpoon performanceTo measure stock performance is always good to compare with competitors or related stocks. We compared Harpoon Therapeutics against in the following table: